Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Update on Potential Therapies for IgE-Mediated Food Allergy

Update on Potential Therapies for IgE-Mediated Food Allergy Curr Allergy Asthma Rep (2017) 17: 4 DOI 10.1007/s11882-017-0671-8 FOOD ALLERGY (T GREEN, SECTION EDITOR) 1,2 Andrew MacGinnite Published online: 8 February 2017 Springer Science+Business Media New York 2017 Abstract Introduction Purpose of Review Food allergy is common, affecting up to 8% of children in the USA. Currently, therapy is lim- IgE-mediated food allergy is present in up to 8% of children in ited to avoidance of the implicated allergen and avail- the USA [1], and is the leading cause of anaphylaxis in chil- ability of self-injectable epinephrine. However, several dren [2]; available data suggests the prevalence is increasing new approaches to food allergy are under investigation. over time [3–5]. Current therapy for food allergy is limited to This article reviews the published data on these new scrupulous avoidance and availability of self-injectable epi- approaches. nephrine. While recent work has demonstrated that early in- Recent Findings Oral immunotherapy, in which allergic sub- troduction of allergenic foods can decrease rates of allergy jects are exposed to increasing amounts of antigen, can be among high-risk patients [6, 7], this approach is less than accomplished in the majority of allergic individuals. 100% effective. New therapies for treatment of patients with However, this http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Current Allergy and Asthma Reports Springer Journals

Update on Potential Therapies for IgE-Mediated Food Allergy

MacGinnite, Andrew
Current Allergy and Asthma Reports , Volume 17 (1) – Feb 8, 2017
Download PDF
7 pages

Loading next page...
 
/lp/springer-journals/update-on-potential-therapies-for-ige-mediated-food-allergy-ElFuibPsbv

References (60)

Publisher
Springer Journals
Copyright
Copyright © 2017 by Springer Science+Business Media New York
Subject
Medicine & Public Health; Allergology
ISSN
1529-7322
eISSN
1534-6315
DOI
10.1007/s11882-017-0671-8
pmid
28181151
Publisher site
See Article on Publisher Site

Abstract

Curr Allergy Asthma Rep (2017) 17: 4 DOI 10.1007/s11882-017-0671-8 FOOD ALLERGY (T GREEN, SECTION EDITOR) 1,2 Andrew MacGinnite Published online: 8 February 2017 Springer Science+Business Media New York 2017 Abstract Introduction Purpose of Review Food allergy is common, affecting up to 8% of children in the USA. Currently, therapy is lim- IgE-mediated food allergy is present in up to 8% of children in ited to avoidance of the implicated allergen and avail- the USA [1], and is the leading cause of anaphylaxis in chil- ability of self-injectable epinephrine. However, several dren [2]; available data suggests the prevalence is increasing new approaches to food allergy are under investigation. over time [3–5]. Current therapy for food allergy is limited to This article reviews the published data on these new scrupulous avoidance and availability of self-injectable epi- approaches. nephrine. While recent work has demonstrated that early in- Recent Findings Oral immunotherapy, in which allergic sub- troduction of allergenic foods can decrease rates of allergy jects are exposed to increasing amounts of antigen, can be among high-risk patients [6, 7], this approach is less than accomplished in the majority of allergic individuals. 100% effective. New therapies for treatment of patients with However, this

Journal

Current Allergy and Asthma Reports – Springer Journals

Published: Feb 8, 2017

There are no references for this article.